Veer Gupta
Overview
Explore the profile of Veer Gupta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
969
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nuytemans K, Franzen S, Broce I, Caramelli P, Ellajosyula R, Finger E, et al.
Alzheimers Dement
. 2024 Nov;
20(12):9014-9036.
PMID: 39535468
Frontotemporal dementia (FTD) is one of the leading causes of young-onset dementia before age 65, typically manifesting as abnormal behavior (in behavioral variant FTD) or language impairment (in primary progressive...
2.
Palanivel V, Gupta V, Chitranshi N, Tietz O, Vander Wall R, Blades R, et al.
PNAS Nexus
. 2024 Aug;
3(8):pgae299.
PMID: 39114576
Neuropeptide Y (NPY), an endogenous peptide composed of 36 amino acids, has been investigated as a potential therapeutic agent for neurodegenerative diseases due to its neuroprotective attributes. This study investigated...
3.
Shen T, Sheriff S, You Y, Jiang J, Schulz A, Francis H, et al.
Aging Dis
. 2024 Jun;
15(5):2315-2327.
PMID: 38916728
Aging is associated with progressive brain atrophy and declines in learning and memory, often attributed to hippocampal or cortical deterioration. The role of brain-derived neurotrophic factor (BDNF) in modulating the...
4.
Mirshahvaladi S, Chitranshi N, Amirkhani A, Rajput R, Basavarajappa D, Vander Wall R, et al.
Proteomes
. 2024 Mar;
12(1).
PMID: 38535505
Neural regeneration and neuroprotection represent strategies for future management of neurodegenerative disorders such as Alzheimer's disease (AD) or glaucoma. However, the complex molecular mechanisms that are involved in neuroprotection are...
5.
Abyadeh M, Gupta V, Paulo J, Mahmoudabad A, Shadfar S, Mirshahvaladi S, et al.
Neural Regen Res
. 2023 Oct;
19(6):1262-1276.
PMID: 37905874
The aggregation of amyloid-beta peptide and tau protein dysregulation are implicated to play key roles in Alzheimer's disease pathogenesis and are considered the main pathological hallmarks of this devastating disease....
6.
Sheriff S, Shen T, Saks D, Schultz A, Francis H, Wen W, et al.
J Clin Med
. 2023 Oct;
12(19).
PMID: 37834863
Purpose: To investigate the relationship between the apolipoprotein E (APOE) ε4 allele and retinal structural and vascular characteristics in older adult participants from several research studies. We also studied the...
7.
Basavarajappa D, Gupta V, Chitranshi N, Viswanathan D, Gupta V, Vander Wall R, et al.
Mol Neurobiol
. 2023 Aug;
60(12):7222-7237.
PMID: 37542647
Glaucoma is a leading cause of permanent blindness worldwide and is characterized by neurodegeneration linked to progressive retinal ganglion cell (RGC) death, axonal damage, and neuroinflammation. Glutamate excitotoxicity mediated through...
8.
Sheriff S, Shen T, Abdal S, Saks D, Mirzaei M, Gupta V, et al.
Neural Regen Res
. 2023 Jun;
18(11):2504-2513.
PMID: 37282483
Examining the retinal tissue has the potential to provide a unique method and technique to quantify Alzheimer's disease-related changes in participants at various stages of the disease. In this meta-analysis,...
9.
Franzen S, Nuytemans K, Bourdage R, Caramelli P, Ellajosyula R, Finger E, et al.
Alzheimers Dement
. 2023 Jun;
19(12):5817-5836.
PMID: 37270665
Frontotemporal dementia (FTD) is one of the leading causes of dementia before age 65 and often manifests as abnormal behavior (in behavioral variant FTD) or language impairment (in primary progressive...
10.
Abyadeh M, Gupta V, Paulo J, Sheriff S, Shadfar S, Fitzhenry M, et al.
Aging Dis
. 2023 May;
14(4):1311-1330.
PMID: 37199411
Alzheimer's disease (AD) is the most common form of dementia that remains incurable and has become a major medical, social, and economic challenge worldwide. AD is characterized by pathological hallmarks...